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Abstract
Background: Reorganisation of healthcare services into networks of clinical experts is increasing as a strategy to
promote the uptake of evidence based practice and to improve patient care. This is reflected in significant financial
investment in clinical networks. However, there is still some question as to whether clinical networks are effective
vehicles for quality improvement. The aim of this systematic review was to ascertain the effectiveness of clinical
networks and identify how successful networks improve quality of care and patient outcomes.
Methods: A systematic search was undertaken in accordance with the PRISMA approach in Medline, Embase,
CINAHL and PubMed for relevant papers between 1 January 1996 and 30 September 2014. Established protocols
were used separately to examine and assess the evidence from quantitative and qualitative primary studies and
then integrate findings.
Results: A total of 22 eligible studies (9 quantitative; 13 qualitative) were included. Of the quantitative studies, seven
focused on improving quality of care and two focused on improving patient outcomes. Quantitative studies were
limited by a lack of rigorous experimental design. The evidence indicates that clinical networks can be effective
vehicles for quality improvement in service delivery and patient outcomes across a range of clinical disciplines.
However, there was variability in the networks’ ability to make meaningful network- or system-wide change in more
complex processes such as those requiring intensive professional education or more comprehensive redesign of care
pathways. Findings from qualitative studies indicated networks that had a positive impact on quality of care and
patients outcomes were those that had adequate resources, credible leadership and efficient management coupled
with effective communication strategies and collaborative trusting relationships.
Conclusions: There is evidence that clinical networks can improve the delivery of healthcare though there are few
high quality quantitative studies of their effectiveness. Our findings can provide policymakers with some insight into
how to successfully plan and implement clinical networks by ensuring strong clinical leadership, an inclusive
organisational culture, adequate resourcing and localised decision-making authority.
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Background
Networks of clinical experts are increasingly being
established as a strategy to promote the uptake of
evidence based practice and drive improvements in
standards of patient care. These clinical networks are
argued to represent a shift away from hierarchical,
bureaucratic organisation of healthcare services to
one which engages clinicians more in the develop-
ment of improved models of care, integration of
services and multidisciplinary collaboration [1, 2].
Broadly, clinical networks provide a structure for cli-
nicians to work more closely across institutional and
professional boundaries, and allow for continuous
working relationships and flow of knowledge about
best practice between individuals and organisations,
thereby improving the quality of and access to care
for patients, including those who require coordination
of care across a range of settings. With this shared
aim, clinical networks have been established in the
United Kingdom (UK) [3–5], other parts of Europe
[6, 7], Australia [1, 8–10], Canada [11], and the
United States (US) [12].
The use of networks to reduce fragmentation and in-
crease efficient and seamless integration of service deliv-
ery is well established in other public services [13, 14].
There has already been significant financial investment.
For example, in the UK NHS England allocated £42 mil-
lion in the 2013/2014 financial year (approximately
$27.7 m USD) to the establishment of strategic clinical
networks to strengthen the existing less formalised clin-
ical networks [15, 16]. In Australia, $58 million AUD
(approximately $48.7 m USD) was allocated in the 2010/
11 Budget for the establishment of Lead Clinicians’
Groups in Local Hospital Networks [17]. However, the
question remains: does the planning and delivery of ser-
vices through clinical networks improve quality of care?
The term “clinical network” has been used to describe
many variants of networks [2, 18] (Table 1). For this re-
view, we excluded information networks, which are
largely soft networks whereby members list themselves
in an electronic directory to receive information and
resources. Studies of fully integrated service delivery
systems were also excluded because they are very con-
textually specific with overarching administrative struc-
tures through which networked services are delivered
(e.g. Kaiser Permanente or the Veterans’ Health Admin-
istration in the US). Additionally, ‘communities of
practice’ were excluded because there has been a sys-
tematic review published which assessed the evidence of
whether they improved the uptake of best practices and
mentoring of new practitioners in the health sector [19].
That review identified 13 primary studies, none of which
met the eligibility criteria for quantitative analysis to
evaluate effectiveness. Consequently, the effectiveness of
‘communities of practice’ in the healthcare sector re-
mains unknown.
Previous systematic reviews [2, 19] of other models of
clinical networks were not able to draw conclusions be-
cause of limited and poor quality research. This is a
fairly common conclusion for reviews of newly estab-
lished, innovative healthcare structures, processes and
systems [20–22]. A large-scale systematic review of clin-
ical networks published in 2004 described models and
functions of networks across multiple public service sec-
tors [2]. That review had a broad focus in order to derive
implications for management, governance, leadership
and policy of networks in health and social care. In rela-
tion to healthcare, this review concluded that there was
no evidence of how effective networks were in improv-
ing patient care. A more recent review focused on the
structure of social networks of health professionals con-
cluded, “cohesive and collaborative health professional
networks can facilitate the coordination of care and con-
tribute to improving quality and safety of care” [23].
The current review focuses on managed and non-
managed clinical networks, defined as voluntary clinician
groupings that aim to improve clinical care and service
delivery using a collegial approach to identify and imple-
ment a range of quality improvement strategies [8] (see
Table 1 for further definitions). The primary aim was to
investigate the effectiveness of these clinical networks to
improve: a) quality of care (for example, increased up-
take of evidence based practice through development
and dissemination of clinical practice guidelines and
protocols, or care pathway redesign); and b) patient
outcomes (based on objective outcome measures). A
subsidiary aim was to identify how clinical networks
achieved their impacts: evidence of impact on quality of
care and patient outcomes from quantitative studies was
supplemented with findings of qualitative research to aid
interpretation of results and facilitate understanding of
the process of network implementation, network struc-
ture, the ways in which networks have been used to im-
prove knowledge sharing and coordination of services,
and key features necessary for success.
Methods
The review was conducted in accordance with the Pre-
ferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) approach [24] (Additional file
1 contains a detailed description of the methods). Re-
view methods were adapted for a mixed methods sys-
tematic review using the framework outlined by Thomas
and colleagues [25, 26] which allows independent syn-
theses of quantitative and qualitative studies followed by
integration of findings. Given the lack of high quality
evidence from randomised controlled trials, we adopted
a pragmatic approach, examining all available evidence,
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from primary observational studies, and assessing quality
within this lower level of the evidence hierarchy using
established protocols.
Search strategy
The search was conducted in two stages (Figs. 1 and 2).
Papers published between 1996 and 2010 were identified
by searching the electronic databases Medline, Embase
and CINAHL, as well as by snowballing. The search was
updated later in PubMed and CINAHL to include publi-
cations between 1 January 2011 and 30 September 2014.
Articles were included if the primary focus was on
clinical networks as defined in Table 1 (see Additional
file 1 for full eligibility criteria). The reviewers independ-
ently reviewed abstracts and selected full text articles to
confirm whether the publication should be included in
the analysis. Discrepancies were resolved through discus-
sion and consensus.
With 17 articles from the initial search and 5 from the
updated search, a total of 9 quantitative and 13 qualita-
tive eligible studies were identified for the search period
1 January 1996 to 30 September 2014.
Quality and assessment of risk bias
Quality assessments of quantitative and qualitative stud-
ies were conducted separately [27, 28]. Two review au-
thors (BB, CP) independently assessed the risk of bias of
each study; discrepancies were resolved by consensus
with a third author (MH) as needed. Studies were
grouped into three categories (high, medium and low).
For the quantitative studies, the reviewers agreed that
observational articles would not be given a “high” quality
rating even when bias was minimised in the study due
to the difficulty in controlling confounding and attribut-
ing causality when using an observational design for
effectiveness studies. Following discussion, there was
Table 1 Typology of clinical networks
Community of practice Information network Clinical network
(non-managed)
Clinical network
(managed)
Integrated service
delivery
Definition Groups of people who
share a concern or
passion for something
they do and learn how
to do it better as they
interact regularly.
Communities of
practice are
characterised by
voluntary and transitory
memberships without a
hierarchical structure.
Soft networks are
largely referral systems
whereby members list
themselves in an
electronic directory to
receive information
and resources.
Groups of voluntary
experts who work
together on common
concerns to develop
solutions that involve
transcending traditional
boundaries. These
networks are
characterised by a
hierarchical structure
with governance
arrangements. These
tend to be organised
by clinical discipline.
Groups of clinicians
who deliver services
across boundaries
between healthcare
professions and the
different sectors of the
health system. These
tend to be organised
by clinical discipline.
Networks made up of
healthcare organisations
as well as individuals
within them with an
overarching
administrative structure
with a focus on
integration and
coordination of clinical
services. These tend to
be organised by
geographical region.
Membership Individuals
Flexible and
unrestricted
Individuals
Flexible and
unrestricted
Individuals
Flexible and voluntary
Individuals and
healthcare
organisations
Formal
Healthcare organisations
Contractual
arrangements about
service delivery
Governance and
management
Non-hierarchical
and informal
“Bottom up”
Non-hierarchical and
informal
“Bottom up”
Semi-hierarchical
“Bottom up”
Hierarchical
“Mix of bottom up and
top down”
Hierarchical
“Top down”
Overlap with
other typology
Enclavea Enclave Individualistic Individualistic Hierarchical
Example Canadian Health
Services Research
Foundation - The
Executive Training for
Research Application
(EXTRA) program
alumni community of
practice, Canada
http://www.cfhi-
fcass.ca/sf-docs/default-
source/extra/cfhi-
extra_brochure-2015-
e.pdf
NHS UK – CHAIN:
Contact, Help, Advice
and Information
Network, UK
http://chain.ulcc.ac.uk/
chain/index.html
NSW Agency for
Clinical Innovation’s
networks, Australia
http://www.aci.health.
nsw.gov.au/
NHS National Services
Division Scotland
Managed Clinical
Networks, UK
http://www.nsd.scot.
nhs.uk/services/nmcn/
index.html
Veterans Integrated
Service Networks,
Veterans’ Health
Administration, US
http://www2.va.gov/
directory/guide/
division_flsh.asp?dnum=1
Included in
this review
Not included Not included Included Included Not included
aEnclave is defined where members are individuals rather than organisations whose participation is voluntary and often transient
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100 % agreement on the quality assessment rating of the
included articles between the three researchers (see
Table 2). Quality ratings were used descriptively to
assess the strength of evidence.
Data extraction and synthesis
Data from quantitative and qualitative papers were ex-
tracted into separate data extraction tables (Additional file
2). Quantitative papers were categorised independently by
two reviewers (BB, CP) according to the focus of the study:
1. quality of care; or 2. patient outcomes (Table 2). Due to
the heterogeneity of the included quantitative studies and
their outcomes, results were reported in narrative form.
Qualitative methods were used to thematically analyse and
synthesise textual data extracted from the qualitative
studies [29]. The two authors independently identified the
focus of the qualitative papers and categorised them under
four agreed themes: 1. features and outcomes of effective
networks; 2. network implementation; 3. organisational
structure; or 4. organisational learning and knowledge
(Table 4). Results from the quantitative narrative analysis
were then integrated with the qualitative synthesis in the
discussion to identify recurrent themes and explain how
successful networks achieved their outcomes.
Results
Additional file 2 presents an overview of the 22 studies
including details of context, sample, research aim, study
design, methods, outcomes and main results.
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Fig. 1 PRISMA Flow Diagram – Initial search 1996–2010
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Synthesis of quantitative studies
Table 2 summarises study characteristics and quality rat-
ings. With the exception of one study published in 1999,
the remainder (eight) were published after 2000, with
four published since 2011. Four studies were undertaken
in the UK, two in France, two in Australia and one in
the US. The studies involved networks covering diverse
clinical specialties including: cancer (three); cardiac
services (two); diabetes (one); end stage renal disease
(one); and neonatal services (two).
Of the nine included quantitative studies, seven fo-
cused on quality of care and two focused on patient
outcomes (see Additional file 2 for measures used in
each study). Based on our quality assessment criteria,
six studies (67) were of moderate quality and three
studies (33 %) were of low quality (Table 2). Studies
were limited by the use of observational rather than
experimental designs (7 of 9).
Four studies assessed the impact of the establish-
ment and reorganisation of healthcare into clinical
networks, while five studies assessed the impact of
network initiatives. Network initiatives included devel-
opment and dissemination of clinical practice
guidelines and protocols, educational activities (e.g.
workshops), clinical audit and provision of feedback,
care pathway redesign, facilitation of multidisciplinary
team care, patient education, and other interventions
to improve clinical care (such as point-of-care
reminders and availability of new technology).
Effectiveness of clinical networks to improve quality of care
A total of seven studies examined quality of care indica-
tors, all of which achieved significant improvements on
some or all indicators. Studies are listed by clinical spe-
cialty. Results are summarised in Table 3 and detailed in
Additional file 2.
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Fig. 2 PRISMA Flow Diagram – Updated search 2011-September 2014
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 Cancer
Three observational studies reported significant
improvements on quality of care indicators related
to previous provision of cancer services. In a
controlled before and after study, Ray-Coquard et al.
[6] reported a significant increase in the observed
compliance rate for overall treatment sequences for
breast (36 v 12) and colon (46 % v 14 %) cancer
(both p < 0.001) post-implementation of clinical
practice guidelines established and disseminated by a
regional cancer network for hospitals in the network.
In the control group of non-network hospitals, there
was no significant difference in the observed compli-
ance rate pre-and post-implementation. In a three-
year follow up repeated controlled before and after
study of the same network clinical practice guideline
implementation initiative, Ray-Coquard et al. [7]
observed that compliance of medical decisions with
clinical practice guidelines was significantly higher in
network hospitals at follow up for colon cancer
(73 % v 56 %; p = 0.003) and similar for the two
periods for breast cancer (36 % v 40 %; p = 0.24).
In the control group, compliance was significantly
higher at three-year follow up for colon cancer
(67 % v 38 %; p = 0.001) and the same for the two
periods for breast cancer. While there was
improvement in compliance for colon cancer in both
networked and non-networked hospitals at three-
year follow up, behaviour change was more rapid in
the region within the cancer network suggesting that
evidence based information was disseminated more
expeditiously through the network and improvements
were sustained over time.
In a retrospective observational study, McCullough et
al. [30] conducted a cohort analysis of patient records
and administrative datasets before and after
establishment of the Scottish Sarcoma Managed
Clinical Network. More patients were seen by more
specialties after establishment of the network and
there were significant improvements in the time
interval from receipt of referral to initial assessment,
the proportion of patients undergoing investigation
with a magnetic resonance imaging (MRI) scan prior
to excision of the sarcoma (67 to 86; p = 0.0009), and
the proportion of patients undergoing appropriate
biopsy (57 % to 79 %; p = 0.006). The rate of complete
resection margins also significantly increased.
 Cardiac services
In one quasi-experimental interrupted time series
study, Hamilton et al. [4] reported statistically sig-
nificant improvement in two out of 16 clinical care
indicators (pain to needle time <90 min; p = 0.05
Table 2 Summary of included quantitative articles
Authors Country Type of network Theme Study design Quality ratinga
Gale et al. 2012 [3] UK Managed clinical
network for neonatal
services
Improving quality
of care
Observational – before and after Moderate
Greene et al. 2009 [31] UK Tayside Diabetes
Managed Clinical
Network
Improving quality
of care
Observational – cross-sectional Moderate
Hamilton et al. 2005 [4] Scotland Managed clinical
network for cardiac
services
Improving quality
of care
Quasi-experimental – interrupted
time series
Moderate
McClellan et al. 1999 [33] USA End Stage Renal
Disease Networks
Improving patient
outcomes
Observational – before and after Low
McCullough et al. 2014 [30] Scotland Scottish Sarcoma
Managed Clinical
Network
Improving quality
of care
Observational – retrospective
before and after
Low
Ray-Coquard et al. 2002 [6] France Regional cancer
network of hospitals
Improving quality
of care
Quasi-experimental – controlled
before and after
Moderate
Ray-Coquard et al. 2005 [7] France Regional cancer
network of hospitals
Improving quality
of care
Observational – before and after Moderate
Spence & Henderson-Smart
2010 [32]
Australia Australian and New
Zealand Neonatal
Network
Improving quality
of care
Observational – before and after Low
Tideman et al. 2014 [34] Australia Integrated cardiac
support network
Improving patient
outcomes
Observational – retrospective
before and after
Moderate
aQuality rating definitions are as follows
• High quality – design and conduct of study address risk of bias, appropriate measurement of outcomes, appropriate statistical and analytical methods, low
drop-out rates, adequate reporting
• Moderate quality – do not meet all criteria for a rating of good quality but no flaw is likely to cause major bias, some missing information
• Low quality – significant biases including inappropriate design, conduct, analysis or reporting, large amounts of missing information, discrepancies in reporting
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Table 3 Summary of findings from quantitative articles
Study Intervention Improvement
observed?
Summary of findings Significant results
Gale et al. 2012 [3] National reorganisation of neonatal
services in England into managed clinical
neonatal networks to improve access to
specialist care for pre-term births
Yes Improvement in
primary outcomes,
less success in
secondary outcomes
Increase in
•Proportion of babies born at 27–28
weeks gestation at hospitals providing
the highest volume of specialist care
(18 % to 49 %; risk difference 31 %;
95 % CI [28 % to 33 %]; OR: 4.30; 95 %
CI [3.83 to 4.82]; p < 0.001).
•Proportion of babies undergoing
acute and late postnatal transfer in
England (7 vs. 12 and 18 % vs. 22 %,
respectively; p < 0.001).
Greene et al. 2009 [31] Progressive implementation of
multiple quality improvement
strategies including; guideline
development and dissemination;
education; clinical audit, feedback and
benchmarking; encouragement of
multidisciplinary team working; task
redesign; and care pathway redesign
Yes Rapid improvement
in simple indicators,
slow improvement in
complex indicators
Improvements (all p < 0.001) in
measurement/assessment and
recording of:
•Glycated haemoglobin
•Blood pressure
•Cholesterol
•Smoking status
•Creatinine
•Foot vascular and neurological status
•Retinal screening
Hamilton et al. 2005 [4] Establishment of a managed clinical
network for cardiac services in a
predominantly rural area to improve
patient care
Some Improvement in 11
indicators (2
significant, 9 non-
significant); no im-
provement in 5
indicators
Improvement in:
•Pain to needle time <90 min; p = 0.05
•70 % on beta-blockade at 6 months
post myocardial infarction; p = 0.05
McClellan et al. 1999 [33] A multifaceted intervention through a
clinical network to improve
haemodialysis adequacy
Yes Improvement in all
primary outcomes
•Improvement in Urea Reduction Ratios
(URRs) from 63 % to 67 % (p < 0.001)
•Decrease in the proportion of under-
dialysed patients from 56.6 % to 31.7 %
(chi-squared for trend, p < 0.0001).
McCullough et al. 2014 [30] Establishment of the Sarcoma
Managed Clinical Network to improve
the quality of diagnosis, treatment and
care of sarcoma patients including
facilitating national multidisciplinary
discussion of all sarcoma cases,
registering case details and provision
of care by a multidisciplinary team
Some Improvement in all
primary outcomes,
but decline in some
secondary outcomes
•Decreased time interval from referral
to initial assessment by the service
from median 19.5 days to 10 days.
•Increase in proportion of patients
undergoing investigation with a MRI
scan prior to excision of the sarcoma
from 67 % to 86 % a (p = 0.0009).
•Increase in proportion of patients
undergoing appropriate biopsy from
57 % to 79 % (p = 0.006).
•Increase in complete resection
margins from 48 % to 81 % (p < 0.001).
Ray-Coquard et al. 2002 [6] Implementation of cancer clinical
practice guidelines (CPGs) through a
regional clinical network
Some Improvement in
compliance to some
clinical guidelines
but not all
Compliance of overall treatment
sequences post-implementation of
clinical practice guidelines in
Network hospitals:
•Colon cancer 46 %; 95 % CI [30 % to
54 %] (56 out of 123) vs. 14 %; 95 % CI
[7 % to 21 %] (14 out of 103); p < 0.001
•Breast cancer 36 %; 95 % CI [30 % to
42 %] (126 out of 346) vs. 12 %; 95 % CI
[8 % to 16 %] (34 out of 282); p < 0.001
Control group:
•No significant difference
Ray-Coquard et al. 2005 [7] Sustained adherence to cancer clinical
practice guidelines within a regional
clinical network
Yes Sustained
improvement in
compliance to
clinical guidelines
Compliance of medical decisions with
clinical practice guidelines at 3-year
follow-up in:
Network hospitals:
•Colon cancer 73 %; 95 % CI [67 % to
79 %] v 56 %; 95 % CI [49 % to 63 %]
respectively; p = 0.003
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and 70 % on beta-blockade at 6 months post
myocardial infarction; p = 0.05) and non-significant
improvement in nine others following the set-up of
a managed care network for cardiac services in
Scotland. Five indicators showed no significant
improvement and there was no impact on costs.
 Diabetes
One study [31] retrospectively evaluated the impact of
quality improvement initiatives undertaken by the
Tayside Diabetes Managed Clinical Network in the
UK using data extracted from the regional diabetes
register. Simple process indicators such as measuring
glycated haemoglobin, blood pressure and cholesterol
rapidly improved, while there was slow continuous
improvement of others (all significance levels p <
0.001). Improvements were greater for type 2 than
type 1 diabetes for which three indicators did not
change significantly. Significant shifts of care for type
2 diabetes into primary care were achieved.
 Neonatal Care
Two observational before and after studies, one in
Australia [32] and one in the UK [3] reported neonatal
care outcomes of neonatal care networks. The
previously established Australian and New Zealand
Neonatal Network [32] drove the implementation of
multiple intervention strategies to increase evidence
based practice for the treatment of pain in the
newborn, resulting in significant improvements across
three outcomes including: increased use of a pain
assessment tool for ventilated neonates; an increase in
the percentage of infants receiving sucrose for
procedural pain (41 % to 61 %; p < 0.005); and increased
staff awareness of a clinical practice guideline for the
management of newborn pain (61 % to 86 %; p =
0.000). Family awareness of infant pain and strategies to
manage pain also increased (19 % to 48 %; p = 0.000).
In the UK, the impact of reorganisation of neonatal
specialist care services for high risk pre-term babies
into managed clinical networks for neonatal services
achieved significant improvements [3]. The propor-
tion of babies born at 27–28 weeks gestation at hos-
pitals providing the highest volume of specialist care
increased significantly (18 % to 49 %; p < 0.001), as
did the proportion of babies undergoing acute and
late postnatal transfer (7 v 12 and 18 % v 22 %,
respectively; p < 0.001). There was no significant
reduction in the number of infants from multiple
births separated by transfer.
Table 3 Summary of findings from quantitative articles (Continued)
•Breast cancer 36 %; 95 % CI [31 % to
41 %] v 40 %; 95 % CI [35 % to 44 %]
respectively; p = 0.24
Control group:
•Colon cancer 67 % 95 % CI [58 %–
76 %] v 38 %; 95 % CI [29 %–47 %]
respectively; p = 0.001
•Breast cancer 4 %; 95 % CI [1 %–
7 %] v 7 %; 95 % CI [3 %–11 %]
respectively; p = 0.19.
Spence & Henderson-Smart
2010 [32]
A multifaceted intervention through a
clinical network to support practice
change and close the evidence-
practice gap for newborn pain
management
Some Improvement in
several primary
outcomes with a
process for
sustainability
established for goals
not achieved
Increase in:
•Percentage of infants receiving
sucrose for procedural pain (41 % to
61 %; p < 0.005)
•Staff awareness of a clinical practice
guideline for the management of
newborn pain (61 % to 86 %; chi
square = 73.8, d.f. 1, p = 0.000)
•Family awareness of infant pain and
strategies to manage the pain (19 %
to 48 %; chi square = 52.3, d.f. 1, p =
0.000).
Tideman et al. 2014 [34] Establishment of a regionalised
integrated Cardiovascular clinical
network to reduce mortality in patients
with acute myocardial infarction in
hospitals in a rural setting
Yes Improvement in all
primary outcomes
•Decrease in 30-day mortality among
patients presenting to hospitals inte-
grated into the clinical network
(13.93 % vs 8.92 %; p < 0.001).
•22 % relative odds reduction in 30-
day mortality compared with patients
presenting to rural centres outside the
clinical network (OR, 0.78; 95 % CI,
0.65–0.93; p = 0.007).
•Increased rate of transfer of patients
to metropolitan hospitals (before
ICCNet, 1102/2419 (45.56 %) vs. after
ICCNet, 2100/3211 (65.4 %); p < 0.001).
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Effectiveness of clinical networks to improve patient
outcomes
Two observational (one prospective and one retrospective
before and after) studies assessed patient outcome mea-
sures, both reporting improvements on primary indicators.
A US study [33] reported positive effects of a quality im-
provement intervention on network-specific Urea Reduc-
tion Ratios (URRs) driven by the End Stage Renal Disease
Network with improvements in URRs during the interven-
tion period (63 % to 67 %; p < 0.001) and a decrease in the
proportion of under-dialysed patients in the networks
(56.6 % to 31.7 %; p < 0.001). Successful intervention strat-
egies included audit and feedback coupled with educational
interventions, involvement of a diversity of physicians and
clinical leaders, and persistence over several years.
In Australia, the regionalised Cardiovascular Clinical
Network (ICCNet) was established to improve outcomes
of patients with myocardial infarction (MI) in rural set-
tings [34]. Among rural hospitals, 30-day mortality de-
creased among patients presenting to hospitals integrated
into the clinical network (13.93 % before ICCNet vs
8.92 % after ICCNet; p < 0.001). After adjustment for tem-
poral improvement in MI outcome, baseline comorbidities
and MI characteristics, presentation to an ICCNet hospital
was associated with a reduction in 30-day mortality com-
pared with patients presenting to rural centres outside the
clinical network. A strong association between network
support and increased rate of transfer of patients to
metropolitan hospitals was observed (before ICCNet,
1102/2419 [45.56 %] vs. after ICCNet, 2100/3211 [65.4 %];
p < 0.001). Increased transfers were associated with a
lower total length of stay compared with admissions be-
fore implementation of the network.
Synthesis of qualitative studies
Table 4 summarises key study characteristics and quality
ratings. All of the 13 studies were published in 2005 or
later. Eight were undertaken in the UK, two in Australia,
two in Canada, and one in Sweden. The majority of stud-
ies used a case study or comparative case study approach
to examine clinical networks. A summary of findings is
available in Additional file 2. Nine of the 13 studies were
given a high quality rating while four were given a moder-
ate quality rating. Although none were rated low quality,
studies were limited by their lack of use of sufficient strat-
egies to establish reliability (e.g. independent coding) or
validity of data analysis (e.g. reporting of negative cases).
While five articles specifically addressed the features
and outcomes of effective networks, there was significant
overlap among articles that described network imple-
mentation, organisational structure and the role of net-
works in organisational learning and knowledge, which
similarly noted the importance of network leadership,
interpersonal relationships, structure and resourcing as
factors that contribute to network effectiveness.
Features and outcomes of effective networks
Five papers [35–39] identified the characteristics that en-
abled networks to be effective in implementing changes
that improved quality of care and patient outcomes. Facili-
tators of and barriers to network success are listed in
Table 5. Of note, the availability of sufficient resources, a
designated project/network leader or coordinator, strong
leadership, a culture of inclusivity, and widespread engage-
ment and participation were recurring features of success-
ful networks. Their absence, particularly inadequate
resourcing and lack of management and leadership, was
noted to hinder networks’ ability to achieve improvement
in quality of care outcomes. The studies noted that suc-
cess was dependent on a combination of these factors be-
ing present rather than just a few isolated features. In
particular, commitment to a set of shared values and ob-
jectives was necessary but insufficient for clinical effective-
ness in the absence of other factors [38].
Outputs of effective networks included the develop-
ment or reorganisation of service delivery into clear clin-
ical pathways, provision of holistic services, improved
working relationships and collaboration within the net-
work, and improved clinical knowledge and skills of net-
work members.
Network implementation
Three articles described the process of implementing
a clinical network and the key lessons learned from
the implementation process [5, 13, 40]. Two of the
studies described positive steps towards the imple-
mentation of clinical networks [5, 13], while one
study described a negative experience [40]. The over-
arching lesson was that the implementation of a net-
work is extremely complex and requires “considerable
time, resources and initiatives at different levels of
the healthcare system” [13]. Successful implementa-
tion required strong leadership, coordination and a
sense of shared values and trust between network
members. While vital, clinical leadership alone was
insufficient [13]. Trust between network members,
whether inter-organisational or inter-professional, was
regarded as being vital to the implementation process.
Members had to be receptive to the concept of the
network. For this, the values of the network had to
match the values of the organisation and of the clini-
cians involved. Power imbalances between institutions
in a network were observed to hinder the implemen-
tation process, as larger institutions were viewed as
“hoarding resources” leaving smaller practices at a
disadvantage, resulting in their disengagement [40].
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The availability of adequate resources for the network
was also essential. This included funding, administration
and human resources. The formalisation of processes
was seen as a positive step, but only when done under
the direction of the clinical teams. Inexperience in
change management and unfamiliarity with leading de-
velopment projects were cited as barriers to implemen-
tation [5]. It was essential for network members to have
confidence in the expertise and ability of the people
leading the changes to the system; where leaders lacked
legitimacy and were perceived to lack the required
knowledge and expertise, implementation was slow.
Having clinical leaders who championed change was es-
sential for buy-in from other clinical staff [5, 13]. Imple-
mentation of the network was also unsuccessful when a
top-down approach was used, where the network was
mandated and led by external organisations rather than
having clinicians set priorities and driving the implemen-
tation process. Without genuine participation of the
physicians involved, implementation was difficult and
did not appear to affect practice [40].
One study reported briefly on some of the outcomes
of the implementation process which were generally
viewed as positive [5]. There were better working rela-
tionships between teams, enhanced knowledge, and a
greater commitment to the practice of evidence based
care. There also appeared to be improved patient out-
comes – interviewed patients reported better manage-
ment of their symptoms and had greater knowledge
about how to manage their condition.
Table 4 Summary of included qualitative articles
Authors Country Type of network Theme Study design Quality ratinga
Addicott 2008 [41] UK Managed clinical network for
cancer services
Organisational
structure
Comparative case study High
Addicott & Ferlie 2007 [42] UK Managed clinical network for
cancer services
Organisational
structure
Comparative case study High
Addicott et al. 2007 [43] UK Managed clinical network for
cancer services
Organisational
structure
Comparative case study High
Addicott et al. 2006 [44] UK Managed clinical network for
cancer services
Organisational
learning and
knowledge
Observational, cross-sectional
organisational process study
High
Ahgren & Axelsson 2007 [35] Sweden ‘Chains of care’ (managed clinical
networks) for patients having the
same illness or symptom
Features and
outcomes of
effective networks
Cross-sectional embedded
multiple-case study
High
Baker & Wright 2006 [36] UK Managed clinical network for
paediatric liver services
Features and
outcomes of
effective networks
Appreciative Inquiry
methodology (case study)
Moderate
Burnett et al. 2005 [45] UK Various managed clinical networks
(cancer, coronary heart disease,
stroke, mental health)
Organisational
learning and
knowledge
Qualitative information and
knowledge needs analysis
(comparative case study)
Moderate
Cunningham et al. 2012 [23] Australia Advisory clinical networks – two
networks for musculoskeletal
health (NSW and WA)
Features and
outcomes of
effective networks
Longitudinal comparative case
study
High
Fleury et al. 2002 [40] Canada Mental health integrated service
network
Network
implementation
Case study and multi-
dimensional analytic model
Moderate
Hogard & Ellis 2010 [38] UK Managed clinical network for
personality disorder
Features and
outcomes of
effective networks
Evaluation Trident methodology
(case study)
Moderate
McInnes et al. 2012 [39] Australia Voluntary collegial clinical
networks in NSW established by
the NSW Agency for Clinical
Innovation
Features and
outcomes of
effective networks
Comparative case study High
Tolson et al. 2007 [5] Scotland Managed clinical network
(Palliative Care), linking primary,
secondary and tertiary care
Network
implementation
Realistic Evaluation
methodology (qualitative pilot
case study)
High
Touati et al. 2006 [13] Canada Managed clinical network (cancer) Network
implementation
Longitudinal qualitative case
study
High
aQuality rating definitions are as follows
• High quality – those meeting 8 or more criteria
• Medium quality – those meeting between 5 and 7 criteria
• Low quality – those meeting fewer than five criteria
The full list of 11 criteria can be found in Additional file 1
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Organisational structure
Three articles looked at how networks were struc-
tured and how network structure affected the ability
to function in the local context [41–43]. All three ar-
ticles referred to a single study of five managed clin-
ical networks for cancer in the UK. Despite
attempting to delegate authority to the local level, the
organisational structure of the networks maintained
decision-making power at a centralised level. Boards
had limited strategic influence, with decision making
power and budgetary responsibilities remaining with
the statutory authorities; only one board was able to
have a noteworthy impact due to the seniority of its
members [41]. Due to the top-down approach used to
set up these networks by the government, the net-
works achieved limited success in organising and
working together effectively, with only one network
emerging as a successful anomaly [41]. At all levels,
network members in positions of less influence strug-
gled to make an impact. Network Management Teams
relied on interpersonal skills to influence members to
cooperate, and were unsuccessful in all but one net-
work [42]. At the local level, a few medical staff
overwhelmingly dominated decision-making in all net-
works, often with the intention of acquiring resources
and/or accreditation status for their own institutions
[42]. An imbalance of power between medical staff
meant that those with less power (typically those cli-
nicians within smaller district hospital units as op-
posed to those working at a major cancer centre)
frequently resisted decisions and implementing
changes due to a perception that their interests were
not taken into consideration [42].
The organisation of the networks also limited their
ability to implement knowledge sharing and educational
activities [43]. Because power and influence remained
centralised and there was strong resistance to any
changes being implemented, there was little impact on
organisational processes. Only one network, where the
Network Management Team was viewed positively and
had an open and facilitative approach to implementing
changes, was able to implement some education and
training activities. The Team was able to successfully le-
verage pre-existing relationships to build support for
and engagement in the network, and adapt interventions
to the local context.
Organisational learning and knowledge
Two papers [44, 45] focused on organisational learning
and the transfer of knowledge within networks. Members
of clinical networks identified organisational learning as a
desirable outcome that could increase individual know-
ledge and improve patient outcomes. They recognised that
easy access to timely information would enable them to
work more efficiently [45]. However not all networks were
able to successfully implement educational measures.
Those that were successful had adequate resources, good
network management, appropriate organisational struc-
ture that facilitated inclusive and open participation, en-
thusiastic network members and a positive learning
environment. Networks where educational initiatives were
unsuccessful were characterised by organisational struc-
tures that impeded knowledge sharing, poor relationships
between network members, weak management and the
perception of increasing competition among members.
Due to the uneven distribution of resources, individuals
competed over resources, which fostered distrust and a
lack of willingness to collaborate. Several respondents be-
lieved education would become more of a priority when
structural issues were addressed [44].
Table 5 Features of successful clinical networks – facilitators and barriers
Facilitators of network success Barriers to network success
Sufficient resources – funding, administration and human (staffing)
Availability of information and communication technologies
A bottom-up, locally-initiated and driven approach to network
implementation, with subsequent formalisation to increase the
adoption of new processes
A positive, trusting culture where networks are seen as desirable and
perceived to be necessary to sharing knowledge, and where there is
open and inclusive communication, clinician engagement and
widespread genuine stakeholder participation
The norms and values of the network are compatible with those of the
organisations involved
Strong leadership, particularly by clinical leaders and network managers
using a facilitative approach
Inclusive membership in the network, including representation of
patients and other stakeholders
Engagement at different levels of the healthcare system
Evidence based work plans and projects that address issues identified by
network members, particularly gaps in current practice, with goals that
are feasible and can be objectively measured
Supportive policy environments and links with government agencies
Lack of funding and resources
Tension, distrust and competition (particularly over resources) between
network members
An imbalance of power between network members resulting in
competition for resources
Poor communication and unwillingness to collaborate
Lack of confidence in the ability of network leaders and managers
Lack of representation of key stakeholders in certain contexts (e.g. rural
and indigenous interests)
Poor record keeping and documentation, which made it difficult to
measure the impact of network initiatives and track progress
A top-down approach of network implementation, or where
implementation is mandated, led by external organisations, and/or
decision-making powers and responsibilities are maintained by
external parties thereby limiting the powers of network members
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Discussion
Testing the effectiveness of clinical networks
There is an emerging, albeit limited, body of empir-
ical quantitative research into the effectiveness of
clinical networks. Amongst the nine studies included,
the majority (seven) focused on improvement in ser-
vice delivery. Only two reported on clinical networks’
impacts on patient outcomes. None of the quantita-
tive studies were of high quality, and several (3 of 9)
were of low quality. All except two used observational
study designs; none used a randomised controlled
trial. The lack of studies with a rigorous design limits
the conclusions that can be drawn. Although the ma-
jority (9 of 13) of the qualitative studies were rated
“high quality” and their findings complement those of
the empirical studies, they were designed to explain
how and why networks may have produced or failed
to produce a desired outcome and were not designed
to determine whether clinical networks could success-
fully improve health service delivery and patient out-
comes, the latter of which is more appropriately
addressed by quantitative studies. None of the studies
used mixed methods study designs, which would be
useful in assessing why a specific network was or was
not effective.
The best available empirical evidence indicates that clin-
ical networks can be effective vehicles for quality improve-
ment. Among the studies reviewed, networks were judged
to improve quality based on several endpoints relating to
both service delivery (such as adherence to clinical guide-
lines and protocols, development of clear patient path-
ways, and use of clinical tools) and patient outcomes
(such as reduced mortality, improvement in biomarkers,
and improved time to treatment). Desirable intermediate
outcomes were also reported in both the quantitative and
qualitative studies, such as improved knowledge amongst
clinical staff and patients, greater clinical collaboration
and greater availability of resources. There is some evi-
dence that clinical networks can be effective in engaging
clinicians in service redesign and reform [13], and devel-
oping and implementing protocols and clinical practice
guidelines [6]. Quality improvement programs undertaken
by networks largely report significant improvements
across several quality of care indicators for a range of clin-
ical disciplines including cancer [6, 7, 30], diabetes [31],
and neonatal care [3, 32]. The two studies reporting pa-
tient outcome measures similarly demonstrated positive
effects of network-specific interventions for end stage
renal disease [33] and reorganisation of cardiac services
[34]. There is some evidence to demonstrate that im-
provements can be sustained over time [7, 33].
Although these findings generally indicate that clinician-
led networks can improve care, other studies have not re-
ported such consistent results. One study examining the
impact of a managed clinical network for cardiac services
on patient care found that only two out of sixteen clinical
care indicators significantly improved [4]. The authors
note that changes were not noticeable until two years after
network start up, which was an intensive process. This
resonates with the findings of other studies [31, 46], which
found simple process measures rapidly improved but that
there was slower improvement across more complex mea-
sures that required intensive professional education or
comprehensive redesign of the care pathway. There was
also variability in the ability of networks to make mean-
ingful network- or system-wide change. A qualitative
comparative case study of five cancer networks in the UK
conducted by Addicott et al. [44] highlighted a great de-
gree of variability in the extent to which networks success-
fully implemented planned activities and the consequent
success of the network. This would suggest that some
quality improvements are likely to be incremental and that
complex changes may take longer to be successfully em-
bedded into routine care. Therefore, while clinical net-
works can be effective in improving care, this is not
always the case.
Features of effective networks
Variability in networks’ success in improving healthcare
is multifactorial and dependent on the local context. Im-
plementation of a clinical network and its initiatives is a
time- and resource-consuming process [4]. Critical fac-
tors for success identified across the qualitative studies
were strong leadership by clinical leaders and managers,
availability of sufficient resources, and involvement of a
broad range of people from different healthcare profes-
sions to patients and other stakeholders. The importance
of leadership was similarly identified in the two quantita-
tive studies [4, 31] that explored facilitators in the estab-
lishment of a network and implementation of network
quality improvement initiatives. Successful networks and
their initiatives were typically driven by a few individual
clinical leaders and dedicated managers who were widely
respected by their colleagues and deeply committed to
the purpose and values of the networks, which may ex-
plain why a strictly ‘top-down’ structure and approach to
network implementation was less effective. Furthermore,
networks without adequate administrative, human and
technological resources were less effective. Several quali-
tative studies reported that lack of a network manager
or project coordinator and insufficient administrative
and technological support to improve communication,
collect relevant data and share educational tools reduced
the effectiveness of networks.
Network structure was also perceived to affect success.
Networks where decision-making power was decentra-
lised to the local level were more successful, particularly
where they were led by highly respected and trusted
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clinical leaders and managers [35, 39-43]. Several partici-
pants in the qualitative studies noted that without an ap-
propriate organisational structure, the networks were
unlikely to be able to change organisational processes
and implement quality improvement measures. This
could partially explain why some networks were able to
change simple process measures like ordering additional
laboratory tests, but were unsuccessful in changing more
complex processes and systems, like clinical pathways,
that may have required the support of a strong network
structure.
These findings are in agreement with those of two
reports that included an examination of what makes
an effective managed clinical network. The first of
these by Guthrie et al. [47] in the UK identified the
following key factors: inclusiveness to ensure that all
relevant stakeholders are actively engaged with the
network; strong credible leadership and effective man-
agement based on negotiation, facilitation and influ-
ence; adequate resourcing for network coordination;
strong two-way communication strategies within the
network; and collaborative relationships with wider or-
ganisational context to ensure network priorities are
aligned with those of individual network members as
well as local, regional and national organisations and
agencies. Respondents in that study additionally
agreed that ‘networks should start with relatively
small, non-contentious issues to achieve some “early
wins” in order to demonstrate the benefits of net-
works and secure broader engagement and owner-
ship’. The current review identified the same. The
second report by Cancer Australia [48] similarly iden-
tified the need for clear and structured management
arrangements with one person acting as the overall
lead coupled with inclusive multidisciplinary represen-
tation. Emphasis was also placed on patient involve-
ment, comparable with the need for inclusive network
membership involving patients and other stakeholders
as well as a broad range of different healthcare pro-
fessions, to ensure alignment of network priorities
with the wider context, and the necessity for forma-
lised reporting requirements to evaluate network qual-
ity improvement initiatives. This report further
stressed the role of clinical networks in the dissemin-
ation of evidence based practice and promotion of
continuing professional development, similar to the
category of organisational learning and knowledge in
the current review.
Consistent with the conclusions of other authors
[49], results of the current review suggest those plan-
ning the establishment of clinical networks should
take a combined ‘bottom-up’ and ‘top-down’ approach
which maintains wide ranging multidisciplinary en-
gagement and allows for decentralised decision-
making to foster a collaborative ethos, coupled with
effective and credible management and adequate ad-
ministrative, human and technological resources to fa-
cilitate communication and collect relevant data.
Strengths and limitations of the review
This is the first systematic review that has explicitly fo-
cused on the effectiveness of clinical networks to im-
prove quality of care and patient outcomes. Like all
systematic reviews, the conclusions of this review are
limited by its scope and the range and quality of the re-
search we have been able to uncover. Clinical networks
are a relatively new phenomenon and it is difficult to
identify relevant papers in any emerging field. This is es-
pecially true of research relating to clinical networks,
which is often classified by clinical specialty. There is a
lack of consistent terminology used to describe clinical
networks, which was particularly evident in the earlier
studies. To facilitate accurate identification of eligible
studies, the researchers worked closely with a librarian
to develop an iterative inclusive search strategy.
Clinical networks have many forms, are hard to define
and operate in different contexts. Further, the reasons
for setting up networks vary, as do their goals and activ-
ities. This is reflected in the diverse aims of the studies
included in this review, which made it challenging to
draw together the findings and any lessons to be learnt.
We have strengthened the utility of this review by sup-
plementing the relatively few quantitative empirical pa-
pers with qualitative research so as to be able to draw
conclusions about the features necessary to enable clin-
ical networks to be effectively used as implementation
vehicles. To the best of our knowledge, this is the first
time quantitative and qualitative results have been syn-
thesised to evaluate clinical networks as an innovative
way to organise healthcare delivery and what makes
them successful.
Future research questions and methods
This review highlights the gaps in the literature relating to
the effectiveness of clinical networks in improving quality
of care and patient outcomes, particularly a lack of empir-
ical studies with rigorous study designs. The absence of
randomised controlled trials and the few observational
studies limits the ability to draw robust conclusions about
whether clinical networks are more effective at improving
health service delivery and patient outcomes than other
approaches.
While results so far have been mostly positive, more
studies are necessary to determine whether improve-
ments in service delivery are translating into
improved patient outcomes. Of note, only two studies
were identified that explicitly measured change in
patient outcome indicators. There is a need to
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strengthen the existing body of knowledge through
higher level evidence from rigorously designed rando-
mised controlled trials to test the impact of clinical
network-led initiatives on both quality of care and pa-
tient outcome indicators. Where it is not possible to
conduct internally and externally valid experimental
studies within a real-world setting, observational stud-
ies with stronger methodological designs, like con-
trolled before-and-after or interrupted time series
studies, would improve upon the learning from the
descriptive studies that are currently most prevalent
in this area. Empirical studies are also needed to
quantify what makes a network more or less success-
ful and determine the features necessary to strengthen
existing and effectively implement new clinical
networks. While the qualitative articles provided
significant narrative on what was perceived to make a
network effective, this was rarely quantified or
examined in any depth in the quantitative studies,
highlighting a need for more mixed methods research.
Furthermore, data on whether clinical networks are
cost-effective vehicles to bring about change in a
complex system is entirely lacking. Only one study re-
ported on the economic impact of the implementa-
tion of a clinical network [4] and found no difference
in the average cost per patient. More comprehensive
economic analyses are required to evaluate whether
clinical networks are a cost-effective way to improve
quality and outcomes through coordinated integration
of services and better flow of knowledge about best
practice.
Conclusions
There is some evidence that clinical networks can be ve-
hicles to implement quality improvement initiatives.
Given that clinical networks are being widely established,
particularly in the UK and Australia, it is important to
develop rigorous evidence to underpin future develop-
ments. Unfortunately, the generally low quality of quan-
titative effectiveness studies limits the ability to draw
conclusions as to whether clinical networks can effect-
ively improve the provision of healthcare and patient
outcomes and whether these improvements can be
maintained. Put simply, the research needs to ‘catch up’
with the operational developments in clinical networks.
Our findings can, however, provide policymakers with
some insight into the planning and implementation of a
clinical network, specifically in regards to organisational
structure, resourcing and interpersonal relationships, in
order to increase the likelihood of success. Policymakers,
clinicians and researchers need to work together in the
implementation of clinical networks and their initiatives
to design rigorous evaluations from the outset so as to
be able to demonstrate their impact.
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